BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ludvigsen E, Stridsberg M, Taylor JE, Culler MD, Oberg K, Janson ET. Subtype selective interactions of somatostatin and somatostatin analogs with sst1, sst2, and sst5 in BON-1 cells. Med Oncol 2004;21:285-95. [PMID: 15456957 DOI: 10.1385/MO:21:3:285] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Cakir M, Dworakowska D, Grossman A. Somatostatin receptor biology in neuroendocrine and pituitary tumours: part 1--molecular pathways. J Cell Mol Med 2010;14:2570-84. [PMID: 20629989 DOI: 10.1111/j.1582-4934.2010.01125.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
2 Sun LC, Mackey LV, Luo J, Fuselier JA, Coy DH. Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice. Clin Med Oncol 2008;2:491-9. [PMID: 21892324 DOI: 10.4137/cmo.s970] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
3 Sherman SK, Howe JR. Translational research in endocrine surgery. Surg Oncol Clin N Am 2013;22:857-84. [PMID: 24012403 DOI: 10.1016/j.soc.2013.06.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
4 Gatto F, Barbieri F, Arvigo M, Thellung S, Amarù J, Albertelli M, Ferone D, Florio T. Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms. Int J Mol Sci 2019;20:E3940. [PMID: 31412614 DOI: 10.3390/ijms20163940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]